These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 33412494

  • 1. Platycodin D reverses histone deacetylase inhibitor resistance in hepatocellular carcinoma cells by repressing ERK1/2-mediated cofilin-1 phosphorylation.
    Hsu WC, Ramesh S, Shibu MA, Chen MC, Wang TF, Day CH, Chen RJ, Padma VV, Li CC, Tseng YC, Huang CY.
    Phytomedicine; 2021 Feb; 82():153442. PubMed ID: 33412494
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sensitization of hepatocellular carcinoma cells to HDACi is regulated through hsa-miR-342-5p/CFL1.
    Nakka P, Jassi C, Chen MC, Liu YS, Liu JY, Yeh CM, Li CC, Chang YC, Kuo WW, Huang CY.
    Cancer Cell Int; 2024 Aug 16; 24(1):291. PubMed ID: 39152428
    [Abstract] [Full Text] [Related]

  • 6. 5-Fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (ΔΨm)-mediated apoptosis in hepatocellular carcinoma.
    Hu XY, Liang JY, Guo XJ, Liu L, Guo YB.
    Clin Exp Pharmacol Physiol; 2015 Feb 16; 42(2):146-53. PubMed ID: 25363523
    [Abstract] [Full Text] [Related]

  • 7. Mitochondrial pathway mediated by reactive oxygen species involvement in α-hederin-induced apoptosis in hepatocellular carcinoma cells.
    Li J, Wu DD, Zhang JX, Wang J, Ma JJ, Hu X, Dong WG.
    World J Gastroenterol; 2018 May 07; 24(17):1901-1910. PubMed ID: 29740205
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
    Chun J, Kim YS.
    Chem Biol Interact; 2013 Oct 05; 205(3):212-21. PubMed ID: 23867902
    [Abstract] [Full Text] [Related]

  • 10. Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.
    Liang RR, Zhang S, Qi JA, Wang ZD, Li J, Liu PJ, Huang C, Le XF, Yang J, Li ZF.
    Int J Oncol; 2012 Sep 05; 41(3):969-78. PubMed ID: 22684543
    [Abstract] [Full Text] [Related]

  • 11. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H, Gao C, Tang H, Zhang H, Roberts LR, Hylander BL, Repasky EA, Ma WW, Qiu J, Adjei AA, Dy GK, Yu C.
    J Hepatol; 2012 Jan 05; 56(1):176-83. PubMed ID: 21835141
    [Abstract] [Full Text] [Related]

  • 12. Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway.
    Liu J, Wei X, Wu Y, Wang Y, Qiu Y, Shi J, Zhou H, Lu Z, Shao M, Yu L, Tong L.
    Cell Oncol (Dordr); 2016 Aug 05; 39(4):333-42. PubMed ID: 27016209
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC, Huang HH, Lai CY, Lin YJ, Liou JP, Lai MJ, Li YH, Teng CM, Yang CR.
    Oncotarget; 2016 Jan 05; 7(1):402-17. PubMed ID: 26587975
    [Abstract] [Full Text] [Related]

  • 15. Platycodin D exerts anti-tumor efficacy in H22 tumor-bearing mice via improving immune function and inducing apoptosis.
    Li W, Tian YH, Liu Y, Wang Z, Tang S, Zhang J, Wang YP.
    J Toxicol Sci; 2016 Jan 05; 41(3):417-28. PubMed ID: 27193733
    [Abstract] [Full Text] [Related]

  • 16. Apicidin-resistant HA22T hepatocellular carcinoma cells massively promote pro-survival capability via IGF-IR/PI3K/Akt signaling pathway activation.
    Hsu HH, Cheng LH, Ho TJ, Kuo WW, Lin YM, Chen MC, Lee NH, Tsai FJ, Tsai KH, Huang CY.
    Tumour Biol; 2014 Jan 05; 35(1):303-13. PubMed ID: 23990456
    [Abstract] [Full Text] [Related]

  • 17. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H, Ge C, Sun H, Li H, Li J, Tian H.
    Cancer Sci; 2018 Apr 05; 109(4):1088-1100. PubMed ID: 29377347
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells.
    Fu M, Wan F, Li Z, Zhang F.
    Biochem Biophys Res Commun; 2016 Mar 04; 471(2):267-73. PubMed ID: 26773495
    [Abstract] [Full Text] [Related]

  • 20. Platycodin D alleviates liver fibrosis and activation of hepatic stellate cells by regulating JNK/c-JUN signal pathway.
    Liu YM, Cong S, Cheng Z, Hu YX, Lei Y, Zhu LL, Zhao XK, Mu M, Zhang BF, Fan LD, Yu L, Cheng ML.
    Eur J Pharmacol; 2020 Jun 05; 876():172946. PubMed ID: 31996320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.